Filing Details
- Accession Number:
- 0001209191-20-061669
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-03 19:23:58
- Reporting Period:
- 2020-12-01
- Accepted Time:
- 2020-12-03 19:23:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1527753 | Personalis Inc. | PSNL | Services-Medical Laboratories (8071) | 275411038 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779787 | Richard Chen | C/O Personalis, Inc. 1330 O'Brien Drive Menlo Park CA 94025 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-01 | 40,000 | $0.44 | 152,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-01 | 14,388 | $27.75 | 138,362 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-01 | 25,612 | $28.14 | 112,750 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-02 | 293 | $27.76 | 112,457 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-01 | 40,000 | $0.00 | 40,000 | $0.44 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-12-01 | 30,000 | $0.00 | 30,000 | $28.17 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 31,884 | 2022-03-07 | No | 4 | M | Direct | |
| 30,000 | 2030-12-01 | No | 4 | A | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The weighted average sale price for the transaction reported was $27.75, and the range of prices were between $27.02 and $28.01. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $28.14, and the range of prices were between $28.025 and $28.43. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- Shares sold to cover tax obligation from settlement of vested restricted stock units.
- The shares subject to the option are fully vested and exercisable.
- The shares subject to the option vest in 12 equal monthly installments starting on April 16, 2023.
Billionaire Hedge Funds
